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Abstract: Fecal incontinence (FI) affects approximately 0.25–6% of the population, both men and
women. The most common causes of FI are damage to/weakness of the anal sphincter muscle and/or
pelvic floor muscles, as well as neurological changes in the central or peripheral nervous system.
The purpose of this study is to report the results of a systematic review of the possibilities and
effectiveness of physiotherapy techniques for the prevention and treatment of FI in women. For this
purpose, the PubMed, Embase, and Web of Science databases were searched for 2000–2020. A total of
22 publications qualified for detailed analysis. The studies showed that biofeedback (BF), anal sphincter
muscle exercises, pelvic floor muscle training (PFMT), and electrostimulation (ES) are effective in
relieving FI symptoms, as reflected in the International Continence Society recommendations
(BF: level A; PFMT and ES: level B). Research has confirmed that physiotherapy, by improving
muscle strength, endurance, and anal sensation, is beneficial in the prevention of FI, both as an
independent method of conservative treatment or in pre/post-surgery treatment. Moreover, it can
significantly improve the quality of life of patients. In conclusion, physiotherapy (in particular, BF,
PFMT, or ES, as effective methods) should be one of the key elements in the comprehensive therapy
of patients with FI.
Keywords: fecal incontinence; physiotherapy; pelvic floor rehabilitation; biofeedback; electrostimulation
1. Introduction
Fecal incontinence (FI) has been defined by the International Continence Society (ICS) as the
involuntary loss of liquid and/or solid stool [1]. The intimate nature of the condition makes it difficult to
accurately determine its prevalence [2]. It has been estimated that FI affects 0.25–6% of the population [3].
It concerns both men and women. It more often affects the elderly, especially patients staying in
nursing homes, and it may be associated with limited mobility and care possibilities [4].
FI can be divided into sub-types: passive FI, when the stool is leaking without any previous feeling
of pressure, urge FI (from overfilling), when the patient feels a push but is unable to stand up long
enough to go to the toilet, and exercise FI, appearing when intra-abdominal pressure increases [1,5].
The cause of fecal incontinence is the improper functioning of anal sphincter muscles, as a result
of their damage and/or neurological changes including the disturbance perception of sensory stimuli
from the anal canal. The weakness of anal sphincter muscles may be caused by perinatal trauma
(e.g., perineal fractures) or trauma during proctological procedures [6]. FI may be caused by disease
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entities associated with frequent diarrhea, including irritable bowel syndrome, Crohn’s syndrome,
or other bowel diseases [7]. Neurological changes may be caused by trauma, cancer, or degenerative
diseases in the central nervous system [8]. FI may also be caused by advanced diabetes mellitus
with polyneuropathy, degenerative changes in muscles (atrophy) and nerves (neuropathy) and pelvic
floor muscle (PFM) dysfunction [5–9]. Risk factors for FI are age, female gender, obesity, smoking,
pharmacotherapy, weakness and trauma of PFM, and the coexistence of urinary incontinence and
organ prolapses [10,11]. The causes of FI differ between women and men. Among men, the problem of
anorectal sensation disorders is more common. Women, on the other hand, are more often affected by
anal sphincter muscles disorders, on the grounds of obstetric trauma and weakened PFM [11,12].
Considering the prevalence of the FI problem, it is important to create a comprehensive system
of treatment, part of which should be physiotherapy. Therefore, the aim of this study was to
perform a systematic review of the literature on the possibilities and effectiveness of physiotherapeutic
techniques, both in the treatment of women with FI as well as for the prevention of the above problem.
1.1. Factors Determining Fecal Continence
Fecal continence is possible due to the appropriate integrity of anatomical structures and
neuromuscular function of the rectum and PFM, as well as rectal compliance and consistency of
stool [13,14]. The anatomical structures responsible for stool continence include the rectum, anal canal,
and PFM, including anal sphincters. The rectum provides continence by maintaining lower pressure
than in the anal canal. The mucous membrane of the anal canal is filled with internal hemorrhoid
tissue which, when expanded, helps to maintain proper resting tonus and ensures tightness [14,15].
The rectum is closed by the permanent tonic action of the internal sphincter muscle and its action can
be supported by the voluntary contraction of the external sphincter muscle [16]. The internal sphincter
of the anus is a smooth muscle that provides 70% of the natural barrier for fecal continence [17]. In turn,
the puborectalis muscle, together with external anal sphincter muscle, are responsible for the conscious
maintenance of the stool while sensing pressure before defecation. The above two muscles are striated
muscles, mainly composed of slow twitch, type I fibers [18]. The rectum is supported by the levator ani
muscle, which belongs to the pelvic floor muscles that support from below the rectum [13]. Part of the
levator ani muscle, the puborectalis muscle, moving away from the pubic bone, runs backwards and
wraps up in the form of loops around the rectum, forming the so-called Parks angle (i.e., the angle
between the anus and the rectum) and closing the anal canal [19]. At rest, the anorectal angle forms
a right angle, during conscious muscular contraction it is at 70◦, while during defecation, it increases
to 110–130◦ [20].
The anorectum is rich in sensory, motor, and autonomic innervations [19]. The internal anal
sphincter and the rectum are controlled by the parasympathetic and sympathetic sacral nerves,
while the external anal sphincter muscle is controlled by the vulva nerve [21]. The sympathetic system
stimulates muscular contraction (i.e., closure of the rectum), while the parasympathetic system relaxes
the muscles, allowing for defecation [22]. The sphincter mechanism reacts differently, depending
on the consistency of the stool, as during defecation and anal stretching, the sensory receptors are
irritated. In response to anal stretching, the inhibitory reflex is triggered. The internal sphincter is
relaxed, preparing the anal canal for defecation [23]. Then, the remaining pelvic floor muscles also
relax, and bowel movements occur. The defecation process can be stopped by voluntary contraction of
the external anal sphincter and the puborectalis muscle. Rectal contractions and the feeling of urgency
on the stool disappears [17].
The problem of fecal incontinence occurs when the rectal pressure is higher than the anal sphincter
pressure. When the anal sphincter is weakened or damaged as a result of increased intra-abdominal
pressure (e.g., chronic coughing, abnormal lifting of objects, or obesity), uncontrolled leakage of stool
may occur [24]. Pelvic muscle contraction stabilizes the pelvic floor organs, in relation to the connective
tissue structures. Therefore, damage to PFM or ligaments (e.g., pubourethral or sacrouterine ligament)
may disturb the proper stool continence [9]. Damage to one element (e.g., nerve, muscle, or ligaments)
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may lead to the dysfunction of other components [21]. Nerve dysfunction results in impaired motor
control, which may lead to constipation, rectal pain, and fecal incontinence [25]. In the case of decreased
rectal sensation, when the rectum is stretched by the stool immediate contraction of the external
sphincter is impossible, which leads to the loss of stool. On the other hand, rectal hypersensitivity may
lead to disproportionately higher sphincter contraction force compared to rectal filling [17].
1.2. Physiotherapeutic Diagnosis in Fecal Incontinence
Physiotherapeutic diagnosis in fecal incontinence includes a detailed history, per vaginam and/or
per rectum palpation, and global postural evaluation [16,26,27]. In the interview, the therapist should
consider questions about the onset of symptoms, their frequency, severity, consistency of stool,
coexisting diseases, conditions, previous injuries, medications, and diet; for women, additional
questions should be asked about their parturitions and course [16]. The pelvis, due to its numerous
muscular attachments, is exposed to muscle imbalance and the influence of disorders even in distant
parts of the body [27]. Studies have confirmed that disorders of spinal curvature and increased posture
defects can affect the development of abnormal respiratory patterns and lead to increased additional
abdominal pressure, which negatively affects the PFM [27,28]. The PFM works together with the
diaphragm and abdominal muscles during respiration. Therefore, the respiratory pattern should also
be assessed [29]. The physiotherapeutic examination should include a global assessment of posture,
spinal mobility, diaphragm, and an examination of the length, strength, and tension of the muscles that
have attachments on the bones forming the pelvis, as well as pelvic angle and the positions of hips,
knees, and feet [27].
Another element of physiotherapeutic diagnosis of PFM is per vaginam and/or per rectum
examination. These allow for the assessment of the correctness and effectiveness of PFM work.
The examination includes voluntary (will-dependent) contraction, used during PFM training,
and involuntary (will-independent) contraction, occurring during increased intra-abdominal
pressure [30,31]. The physiotherapist may also use EMG, perineometer, and palpation to evaluate the
PFM function [32,33]. The perineometer is used to assesses vaginal pressure, while the EMG records
the electrical activity of muscle fibers [32–34]. PFM palpation is a common, fast, and inexpensive
examination which should be performed by an experienced therapist. PFM palpation is widely used
in both diagnostics and scientific research [32].
The PERFECT system with modified OXFORD scale is used for the per vaginam and/or per rectum
palpation [35]. Laycock et al. described the PERFECT scale as a test for power (P), endurance (E),
slow-twitch fiber capacity (R), fast-twitch fiber capacity (F), PFM contraction standard (E), abdominal
transverse muscle contraction (C), and PFM involuntary contraction when abdominal pressure
increasing during cough (T) [26,34]. The strength of the PFM is assessed using the Modified Oxford
Scale, in which 0 to 5 points can be obtained, where 0 means no contraction and 5 means strong
contraction against resistance [26,30]. A detailed description of the PERFECT test scheme is given in
Table 1. Briefly, in order to assess the PFM strength, the woman is asked to keep the contraction as
long as possible. Strength is expressed as the time when the strength of the maximum contraction
decreases to half of its value. Examination of the efficiency of the slow twitch fibers is based on the
highest possible number of contractions of maximum strength [34]. On the other hand, the efficiency
of fast twitch fibers is assessed by the number of maximum one-second contractions and the fastest
possible muscle relaxation between contractions [30]. The physiotherapeutic diagnosis of PFM also
evaluates the contraction pattern. During voluntary and involuntary contractions, the PFM should
lift up in a cefalo-ventral manner [34]. The co-contraction of the transverse abdominal muscle, which
should occur together with both arbitrary and involuntary PFM contraction, is assessed further [36].
The reflective reaction of PFM to an increase in intra-abdominal pressure (cough test) is assessed as the
last element. The PFM contraction appearing with increased abdominal pressure protects the pelvic
floor against pelvic organ depression [32]. The palpation test also pays attention to muscle tonus,
where the therapist checks whether the resting pressure of PFM is normal, lowered, or increased [34,37].
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Table 1. PERFECT examination scheme of pelvic floor muscle (PFM).
P Performance
Strength of maximum voluntary contraction (MVC) evaluated in the Oxford Modified Scale
0 no contraction
1 flickering or pulsation
2 poor tension without lifting the vaginal walls
3 moderate tension with vaginal walls lifting without resistance
4 contraction with lifting of vaginal walls leading to join fingers in the vagina withouttherapist resistance
5 strong contraction leading to join fingers in the vagina against resistance
E Endurance Muscle strength assessed in seconds (0–10) as the ability to maintain an MVC until it fallsto 50% of MVC
R Repetition Number of MVC repetitions (0–10) of the length diagnosed in the endurance section
F Fast Performance of fast twitch fibers evaluated as the number of repetitions (0–10) ofone-second MVC
E Elevation Cefalo-ventral elevation of PFM
C Co-contraction Reflex co-contraction of the transverse abdominal muscle during the contraction of the PFM
T Timing Involuntary PFM contraction during coughing provocation
A global study of posture, pelvic statics, and pelvic floor muscles, completed with appropriate
questionnaires, allows for an accurate functional evaluation of PFM, as well as the proper conduct of
therapy [38]. The questionnaires most commonly used in fecal incontinence are the Wexner scale of
incontinence severity [39], the Fecal Incontinence Quality of life (FIQOL) [40], the Fecal Incontinence
Severity Index (FISI) [41], and Fecal Incontinence Severity Score (FISS) [42].
2. Materials and Methods
The literature review was conducted in the Medline-PubMed, Embase, and Web of Science
databases. The keywords used were the following expressions: fecal incontinence physiotherapy,
fecal incontinence rehabilitation, fecal incontinence physical exercises, fecal incontinence exercises,
fecal incontinence biofeedback, fecal incontinence magnetic stimulation, fecal incontinence electrical
stimulation, and fecal incontinence pelvic floor training.
The review included studies on the influence of various physiotherapeutic methods in the
treatment and prevention of fecal incontinence in women. Articles only in English with studies
published from January 2000 to April 2020 were qualified. The exclusion criteria were as follows:
Language of publication other than English, conducting or publishing the studies before 2000, and/or
failure to demonstrate the influence of physiotherapy on the treatment of fecal incontinence in women.
Furthermore, articles in which men were also examined, in which it was impossible to separate the
results for women only, were also rejected. Systematic reviews, letters to the editorial office, master’s or
doctoral theses, summaries of conference speeches, study protocols, and studies that did not address
fecal incontinence in women were not included. The review was conducted by two independent
authors with the methodology following the PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) rules.
3. Results
In total, 1510 articles were found. After removing duplicates, 860 publications remained. Finally,
166 articles were left to be fully read. On the basis of inclusion and exclusion criteria, 22 publications
qualified for review. The PRISMA diagram (Figure 1) was used to describe the particular stages of
the review. The diagram presents the reasons for publication exclusions and the final number of
studies included in the analysis. Randomized studies were evaluated using the Pedro scale (Table 2).
The Pedro scale is used to critically assess randomized clinical trials. Publications are evaluated in
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11 categories, with a maximum score of 10 points (eligibility criteria are not included in the total
score) [43]. Moreover, Table 3 presents a short description of the qualified studies.J. Clin. Med. 2020, 9, x FOR PEER REVIEW 5 of 21 
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Bø, 2011 [44] + + + + - - - - + + 5
Stafne, 2012 [45] + + + + - - - + + + + 7
Johannessen, 2017 [46] + + - + - - - - + + + 5
Ilnyckyj, 2005 [47] + + - - - - - - - + - 2
Sjödahl, 2015 [48] + + + + - - - + - + + 6
Peirce, 2013 [49] + + + - - - - + - + - 4
Davis, 2004 [50] + + - + - - - - - + + 4
Ghahramani, 2016 [51] + + + + + + + + + + + 10
Sigurdardottir, 2020 [52] + + - + - - + + - + + 6
Naimy, 2007 [53] + + - - - - - - - + + 3
Mahony, 2004 [54] + + + + - - + + - + + 7
Healy, 2006 [55] - + - - - - - - - + + 3
Coh n-Zubary, 2015 [56] + + + + - - - + + + 6
Ugwu, 2018 [ 7] + + + + - - + - + + 6
* Eligibility criteria it is not included in the total score; EC, Eligibility criteria; RA, Random allocation; CA, Concealed
allocation; BC, Baseline comparability; BS, Blind subjects; BT, Blind therapists; BA, Blind assessors; AF, Adequate
follow-up; ITA, Intention-to-treat analysis; BGC, Between-group comparisons; PeaV, Point estimates and variability;
TS, Total score (1 point: “+”; 0 point: “-”).
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Table 3. Characteristics of comparators of studies qualified for the review.
Study Qol Depression UI FI CI SPF PFMF Other
Bø, 2011 [44] + + GI
Stafne, 2012 [45] + + + TD
Johannessen, 2017 [46] + + + EaU
Ilnyckyj, 2005 [47] + + BD
Sjödahl, 2015 [48] + + BD, EaU
Peirce, 2013 [49] + + + + + + EaU
Coffey, 2002 [58] + + +
Damin, 2017 [59] + + +
Collins, 2016 [60] + + +
Davis, 2004 [50] + + + + EaU
Ghahramani, 2016 [51] + + EaU
Lacima, 2016 [61] + + + EaU, PNTML, BD
Sigurdardottir, 2020 [52] + + + +
Mathé, 2016 [62] + + + + GI
Naimy, 2007 [53] + + +
Worsøe, 2011 [63] + + + + BD
Mahony, 2004 [54] + + + EaU
Healy, 2006 [55] + + EaU, PNTML
Cohen-Zubary, 2015 [56] + + + + GI
Shobeiri, 2007 [64] + + + EvU
Ugwu, 2018 [57] + + + GI
Eogan, 2006 [65] + + EaU, PP
Qol, Quality of life; UI, Urinary Incontinence; FI, Fecal Incontinence; CI, Childbirth injury; SPF, Self-perceived
function; PFMF, Pelvic Floor Muscle Function; GI, gas incontinence; EaU, endoanal ultrasound; EvU, endovaginal
ultrasound; PNTML, pudendal nerve terminal motor latency; BD, Bowel symptoms diary; TD, training diary;
PP, perineal pain.
4. Prevention of Fecal Incontinence
Analysis of the available literature has shown that the aspect of the application of physiotherapeutic
techniques in the prevention of FI is a poorly researched issue, where only a few studies have focused
on this topic. Nevertheless, bearing in mind the main components that determine stool continence,
it is important to maintain the proper function and efficiency of PFM, including anal sphincters,
in the prevention of FI [66]. For FI prevention in women, attention should be paid to the period
of pregnancy and childbirth. Bearing in mind that childbirth is a significant risk factor for perineal
injury and FI development, the possibility of implementing primary and secondary prevention of FI
seem to be particularly important. Bø et al. [44] examined the influence of regular fitness training,
including PFM exercises, in pregnant women for mitigating postpartum incontinence. Incorporation of
PFMT into standard fitness training was not effective in relieving postpartum incontinence, which the
authors explained by a lack of individual instruction regarding PFM contraction and no control
of the contraction correctness by transvaginal palpation [44]. A similar study was conducted by
Stafne et al. [45], where PFM exercises were added to the general exercise course consisting of aerobic
exercise, stretching, and balance training. Additionally, pregnant women were obliged to perform
training at home. They were encouraged to perform PFM contractions after a physiotherapist’s
instruction and a transvaginal assessment of the correctness of PFM contraction. PFMT conducted in
this way significantly reduced the intensity of both UI and FI incidents [45]. These studies emphasized
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the important role of professional instruction and transvaginal control of contraction in the effectiveness
of PFMT. Detailed descriptions of these studies are presented in Table 4A. Physiotherapeutic prevention
of FI includes maintaining proper tension and PFM strength. The basic procedure is PFM exercises,
which can be supported by biofeedback [24,67]. In the case of PFM hypertonic tension, it is necessary
to relax them by appropriate therapy [67].
Another physiotherapeutic technique in relation to which the literature confirms its effectiveness
in the prevention of FI is perineal massage performed in late pregnancy. Antenatal perineal massage
provides relaxation, improves the blood flow within the perineum, and makes the pelvic floor muscles
more flexible [57]. Studies have shown that pelvic floor massage is safe and well tolerated by women [68]
and may significantly reduce the risk of perineal injuries during delivery [69]. As perinatal perineal
injuries are a risk factor for the development of FI [70], such massage may provide a preventive measure
for maintaining proper continence [71]. Moreover, the consequences of perinatal injuries of the pelvic
floor include not only the development of urinary or fecal incontinence but also perineal pain, sexual
disorders, as well as decreased quality of delivery [69]. The study carried out by Ugwu et al. [57]
showed that 10 min of daily massage from the 34th week of pregnancy reduces the risk of developing
incontinence of feces, urine, and gases. However, Eogan et al. [65], in a similar study, observed only a
tendency to reduce the risk of anal sphincter injuries could be caused by the shorter massage time
(5 min). Therefore, it is recommended that it is performed daily for 10 min from the 34th week of
pregnancy until delivery [57,72]. Antenatal perineal massage can also be combined successfully with
other physiotherapeutic techniques, such as pelvic floor training [73]. Descriptions of the studies
included in this review are presented in Table 5.
Referring to the issue of FI prevalence, the role played by women’s education and proper toilet
habits cannot be ignored. Appropriate toilet habits are particularly important, both in the prevention
and treatment of PFM dysfunction. The natural position for defecation is the tuck position, in which
the anorectal angle becomes open and allowing the fecal mass to move freely. This position should be
reached on the toilet by placing a support under the feet. This avoids pushing and, thus, increases
pressure in the intra-abdominal cavity, lowering the PFM and weakening them [74]. The toilet should
be used at the same time, as the nervous system is then accustomed to regularity. After using the
toilet, the PFM should be always pulled up as during their exercise [2]. Proper diet and hydration
should be also taken, in order to ensure the proper consistency of the stool [75]. Physical activity is
also important here, which contributes to maintaining proper body weight and accelerating intestinal
passage, thus avoiding constipation [13].
In conclusion, proper women’s education and correct toilet habits are important for the prevention
of FI, as well as the implementation of PFM training by a specialist, which should be preceded by
verification of the functional state of the pelvic floor, in order to adjust the training to the woman’s
needs. In late pregnancy, perineal massage may be considered, in order to better prepare the structures
for delivery and reduce the risk of perineal injuries.
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Table 4. Characterization of selected studies on the effects of pelvic floor muscle training (PFMT) on the fecal incontinence prevention (A) and treatment (B).
Reference Main Objective Participants Intervention Outcome
(A) Pelvic floor muscle training (PFMT) in fecal incontinence prevention




The effectiveness of PFM
exercises conducted during
general fitness classes in
pregnant women for mitigating
postpartum incontinence.
84 pregnant women
Exp.: 42 (aged 31.2 ± 3.7 years)
Con.: 42 (aged 30.3 ± 4.4 years)
Exp.: 1 h general fitness classes with PMFT
(3 × 8–12 PFM contractions, hold 6–8 s);
2–3 times a week per 12 weeks + 30 min additional
home exercises
Con.: w/o interventionAssessment: SI, ICIQ–UI SH,
No efficacy of PFMT conducted
during general fitness classes in







Comparison of the effectiveness
of general exercise course
including PFMT with standard
care in the prevention of UI and
FI in late pregnancy
761 pregnant women
Exp.: 396 (aged 30.5 ± 4.4 years)
Con.: 365 (aged 30.4 ± 4.3 years)
Exp.: general exercise with PFMT (1 h, once a week
under physiotherapist supervision + 45 min at home,
twice a week per 12 weeks)
Con.: standard care w/o exercise
Assessment: SI, St. M.S, questionnaire about PFMT
Pregnant women who regularly
participated in the training
program reported UI and FI less
frequently in late pregnancy.





Assessment of the effectiveness
of individualized PFM training
in the treatment of FI in the
postpartum period
109 women with FI 1 year postpartum
Exp.: 54 (aged 29.7 ± 4.3 years)
Con.: 55 (aged 30.6 ± 3.8 years)
Exp.: individually adapted home PFMT program:
3 sets of 8–10 maximum PFM contractions per day, 3 s
long with progression to 10 or 12 s with 3 fast
contraction at the end, for 6 months
Con.: written information about PFMT, training was
not obligatory.
Assessment: St. M.S, EaU, manometry, VPFMC
Both interventions reduced the
symptoms of FI,
howeverregular, individualized
PFMT in the postpartum period
reduced them significantly
more, which has been described
as a clinically significant effect.




Comparison of the effectiveness
of early PFMT and/or standard
rehabilitation for FI symptoms
after vaginal deliveries
complicated by ≥3rd degree of
perineal tears
167 women with ≥3rd degree of
perineal tears after vaginal delivery
Con.: 83 (age: 29.5 ± 4.7 years)
Exp.: 84 (age: 30.6 ± 4.1 years)
Con.: standard rehabilitation, PFMT from 6–8 weeks
of puerperium + BF as supports + education
Exp.: early rehabilitation, PFMT after 30 days
postpartum (6–10 series of PFMT twice a day) +
standard rehabilitation (as in the group Con.)
Assessment: Modified version of the Jorge and
Wexner questionnaire
The implementation of early
rehabilitation significantly
reduces FI, GI, and UI in women
after childbirth complicated by
massive perineal damage,
this result was significantly
better than that obtained after
standard rehabilitation.
Exp., experimental group; Con., control group; PFMT, pelvic floor muscle training; FI, fecal incontinence; UI, urinary incontinence; GI, gas incontinence; PFM, pelvic floor muscles; SI,
severity index; ICIQ-UI SH, International Consultation of Incontinence Questionnaire Urinary Incontinence Short Form; St. M.S, St. Mark’s score; VPFMC, voluntary pelvic floor muscle
contractions; EaU, endoanal ultrasound; BF, biofeedback.
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Table 5. Studies assessing the role of antenatal perineal massage in fecal incontinence prevention.
Reference Main Objective Participants Intervention Outcome





effectiveness of APM in
the prevention of
perineal injuries and FI
development.
108 primiparous at 34–36
weeks of pregnancy
MG: 53 (Average Age:
28.02 Years)
Con.: 55 (Average Age:
28.77 Years)
MG: perineal massage,
10 min a day until delivery
Con.: no intervention







lowers the risk of FI
after childbirth.




impact of APM on the
prevention of stool
disorders
MG: 100 primiparous at







5 min a day until delivery
Con.: no intervention
Follow up after 3 days and






pain. There were no
significant differences in
the manometry results
between the two groups.
FI, fecal incontinence; APM, antenatal perineal massage; MG, massage group; Con., control group; PS, Pain Scale;
EaU, endoanal ultrasound.
5. Physiotherapeutic Techniques for the Treatment of Fecal Incontinence
Both surgical and conservative methods are used for the treatment of FI. Surgical interventions are
aimed at anatomical and functional correction of the rectum, pelvic floor, or anal sphincters. In turn,
conservative methods of FI treatment include physiotherapeutic techniques [76], such as patient
education, pelvic floor and sphincter muscle training with or without biofeedback, electrostimulation,
and manual therapy techniques [77]. Bearing in mind the recognition of physiotherapy as an important
element in the therapy of women’s FI, below, we present a systematic review of the techniques described
in the literature.
5.1. Pelvic Floor and Anal Muscle Training for the Treatment of Fecal Incontinence
The main objectives of physiotherapeutic muscle training in FI are to increase the strength, tension,
endurance, and co-ordination of anal sphincter and pelvic floor muscles [18,77]. Anal training is based
on the co-ordination of anal sphincters as well as isolation of their contraction [77]. An increase in the
tension and strength of anal sphincters can lead to an improvement of anal canal capacity and facilitate
the process of defecation [78,79], as well as potentially improving the level of resting anus closure
pressure [80]. Therefore, for a better therapeutic effect and depending on the stage of FI advancement,
muscle training can be combined with other techniques [77].
Exercise patterns in FI differ in type, number, and intensity of exercises from one exercise pattern
for everyone (e.g., 10 strong contractions, per 5 s, five times a day), such that the training program
should be individualized depending on the initial muscle parameters (i.e., strength and endurance) [80].
It is important that PFM training reduces the risk of developing FI, compared to standard care [45] or
lack of exercise [46], and that it is more effective in the case of supervised training [45,46], as well as
when preceded by transvaginal assessment and correction of PFM contraction [45]. Research suggests
that early PFMT during the puerperium can effectively reduce the consequences of severe obstetric
injuries [62]. In addition, to achieve a positive PFM training effect, the exercise should be done
regularly [44]. It should also be noted that not every woman can perform the correct PFM contraction,
in spite of instruction, which significantly reduces or even excludes the effectiveness of training.
In such a situation, it is necessary to implement techniques aimed at PFM sensitization. It is estimated
that nearly 25% without UI/FI symptoms and over 70% of women with PFM disorders face this
problem. In these cases, basing physiotherapy solely on PFM exercises will be limited in effectiveness,
as summarized in our previous work [81]. Therefore, PFM training should be preceded not only by
a verbal exercise instruction, but also by transvaginal control and supervision by a physiotherapist in
order to achieve optimal therapeutic effects. Unfortunately, most of the studies on the effectiveness of
muscle training in the treatment of fecal incontinence have been carried out in the general population
(both men and women) and it is often not possible to separate the results only for women. Moreover,
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it should be noted that PFMT is often the basic procedure recommended for control groups, in relation
to which the effectiveness of tested techniques is measured. This proves the high recognition of
exercise as a form of primary action in the treatment of FI. PFMT has been recommended by ICI-ICS as
an effective method in the treatment of FI with a grade of recommendation of B [82,83]. In addition,
ICI has recommended exercise as the first line of FI therapy [82]. Descriptions of the studies included
in the review are presented in Table 4B.
5.2. PFM Training with Biofeedback for the Treatment of Fecal Incontinence
Inability to proper identify and isolate of PFM contractions have been included among the
main obstacles to urogynoecological rehabilitation [79]. Biofeedback is one of the techniques that
supports the learning and facilitation of PFM exercises [84], helping to isolate appropriate PFM [52]
and anal sphincter contractions [24] without the co-contraction of other muscles. Biofeedback is
a commonly used technique based on operant conditioning by using devices that provide the patient
with acoustic or visual feedback on the quality of muscle activation. In the management of FI,
biofeedback techniques include anorectal manometry and surface or endoanal EMG. Depending on
the technique used, the patient receives information about their muscle activity or a change in anal
canal/rectal pressure [85].
Biofeedback training improves rectal sensory function, strength, and the co-ordination of pelvic
floor muscles [86] and, as research has shown, is effective in alleviating FI symptoms in nearly 75%
of cases [61]. Improvement in the quality of life and/or a reduction in the severity of symptoms has
been observed both in patients with idiopathic FI [47], with FI of different etiologies [61], and with
fecal incontinence associated with scleroderma [60]. A positive effect of BF therapy has also been noted
in patients after childbirth complicated by damage to the sphincters [52,58]. BF training has been
demonstrated to be effective both in the model of pre- or post-FI surgery due, for example, to damage
to the sphincters [50,51], as a stand-alone therapy in moderate FI [60], and in the prevention of FI [49].
BF can be combined with PFM training, FI education and pharmacological treatment, which effectively
reduced FI symptoms and risk of FI development [47,48]. It should be noted that BF training can
be successfully performed in both outpatient and home-based conditions [87], as well as in different
positions and movements [88]. A significant difficulty in the physiotherapy of pelvic floor dysfunction
is the low effectiveness of unsupervised home training, which has been particularly emphasized by
research on PFM training [49]. Nevertheless, the protocol proposed by Damin et al. [59], testing a new
BF device for home training, showed promising results in both the reduction of FI symptoms as well
as a significant improvement in the quality of life of women. Moreover, studies have shown that,
by combining training with biofeedback, a better therapeutic effect can be achieved in the management
of FI than by education or PFM exercises alone [80]. The significant number of studies evaluating
the effectiveness of this method in alleviating the symptoms of FI led it to being recommended by
the ICI-ICS at the highest level (Level 1, grade A); however, it is recommended in the second line of
therapy [83]. Nevertheless, it should be kept in mind that the necessary conditions for the application
of the BF technique is the appropriate strength of the muscles, making it possible to contract them.
In the case of patients with severe muscle weakness, it is appropriate to first apply electrical stimulation
or PFM sensitization techniques. For this reason, prior to incorporation of this technique into FI therapy
per vaginam or per rectum, PFM examination should be performed by an experienced physiotherapist.
This allows for the assessment of whether the possible lack of a perceptible contraction of PFM is the
result of significant muscle weakness, the inability to activate them, or the need to use PFM sensitization
techniques. Descriptions of the studies included in the review are given in Table 6.
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Table 6. Characterization of selected studies on the effects of the biofeedback (BF) technique on the severity of fecal incontinence symptoms.
Reference Main Objective Participants Intervention Outcome




Assessing whether BF has any
specific effect beyond the
standard educational
intervention




Con.: education on FI and PFM and verbal
instruction of PFM exercises (6 times a day,
5 contractions with maximum possible force
and holding time separated by a 20 s pause).
Exp.: education and PFM exercise as in the
Con.: group + BF training
Assessment: manometry, diary
Education with exercise instruction
and BF effectively minimize the
symptoms of FI in women. In both
groups, there was a significant
improvement in squeeze duration;
however, resting and squeeze
pressures improved only in the group
with BF.




Evaluation of the therapeutic




57 women with FI history ≥ 1 episode of
FI within 2 weeks
BF + Pharmaco: 29 (median age 62 years)
Pharmaco + BF: 28 (median age 57 years)
A combination of BF therapy and subsequent
pharmacotherapy or vice versa
BF: education, behavioral instructions and
surface electro-BF training with anal plug
(1–6 session during 4–6 months with
individual home exercise program)
Pharmaco: loperamide and stool-bulking
agents for 2 months
Assessment: 14 day symptoms diary,
3D-EAUS, anal function
Both type of combined interventions
significantly reduced the FI
symptoms and was more
effectiveness than BF or
pharmacotherapy alone (significant
reduction in urgency, number of loose
stools, leakages without forewarning,
and passive leakages were observed).




Comparison of early home BF
physiotherapy with PFM




120 Primiparous women with a primary
third-degree perineal tear
Exp.: 30 (aged nd)
Con.: 90 (aged nd)
Exp.: home EMG BF therapy with the
intra-anal probe, twice a day for 3 months
(10 contractions, 5 s duration, 10 s rest)
Con.: home PFMT (5 min standard Kegel
exercise) twice a day for 3 months.
Assessment: anorectal manometry, EAU,
CCCS, RFI QoL
No additional benefits of BF therapy
compared to PFMT have been
demonstrated. There was no
difference in the manometric test,
FI symptoms and quality of life
between the groups.
Coffey et al. (2002),
USA [58]
Case Report
Evaluation of the effectiveness
of multifactorial therapy
designed to reduce the PFM
dysfunction and FI symptoms.
30 year old woman with FI symptoms
from 8 years which started after the first
delivery (vacuum extraction, perineal
incision, child’s weight 4.16 kg)
Education, EMG BF, strengthening
exercises, PFM relaxation training, soft tissue
techniques,
Follow up: 4 months
Assessment: authors questionnaire, digital
palpation, EMG BF
As a result of the therapy
improvements have been achieved in
such aspects as the quality of life,
PFM strength, endurance and control.
FI symptoms was also improved.
Damin et al. (2017),
Brazil [59]
A pilot study
Verification of the usefulness of
a novel portable biofeedback
device in the FI treatment
10 women with FI, without any previous
treatment
(aged 50–73 years)
BF training: daily for 28 days, 20 min in three
phases (1) 5 series of 10 2-s contractions with
a 2-s rest between contractions, (2) 2-min
break, (3) 5 series of 10 contractions during
5 s with a 5 -second rest. PFM contractions of
maximum strength
Assessment: Wexner scale, FIQL
A reduction in FI symptoms and an
increase in QoL were achieved.
The BF device allows for effective
training for FI treatment at home.
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Table 6. Cont.
Reference Main Objective Participants Intervention Outcome
Collins et al. (2016),
Australia [60]
A case-control study
Assessment of the effectiveness
of anorectal BF in the treatment
of FI and QoL improvement
among patients with
scleroderma compared to
patients with functional FI.
39 women with FI
G.I.: 13 women with FI and scleroderma
(median age 59, IQR 47–65 years)
G.II.: 26 women with functional FI (age-
and parity-matched)
Both groups: supervised BF training
(30–60 min), once a week for 6 weeks,
education, BF and PFMT learning, anal
sensory training.
Follow up: 6 weeks and 6 months after the
end of therapy
Assessment: FISI, manometry
BF training improved quality of life
and stool control in both groups.
Patients with scleroderma benefit
from BF comparable as patients with
functional FI.




To evaluate the effect of BF as
adjuvant therapy in women
after anal sphincter surgery.
31 women with FI referred to a
secondary/tertiary colorectal unit
Con.: 17 (aged 60.29 ± 13.59 years)
Exp.: 14 (aged: 60.71 ±10.04 years)
Con.: anal sphincter surgery
Exp.: BF 3 months after sphincter surgery;
session duration 1 h, once a week for
6 weeks, education, BF, and PFMT twice a
day at home.
Assessment: CGSS, manometry, EaU
Anal sphincter surgery significantly
reduces the FI symptoms.
Postoperative BF therapy improves





Assessment of the effect of BF
applied before and/or
after surgery on FI symptoms in
women with sphincter damage.
27 women with the anal sphincters
damage during childbirth
Exp1: 9 (aged: 41.1 ± 13.12 years),
Exp2: 9 (aged: 36.8 ± 16.45 years),
Con.: 9 (aged: 44.85 ± 15.32 years),
Exp1: BF 3 months before and 6 months
after surgery
Exp2: BF 6 months after surgery
Con.: operation only
BF: supervised training—10 sphincter muscle
contractions maintained for 5 s, education; at
home—100 contractions of the anal sphincter
muscles twice a day
Assessment: The Wexner scale,
manometers, EaU
Surgery alone and in combination
with BF reduce the FI symptoms in
women. The use of BF before and/or
after surgery provides better FI
improvement than surgery alone
(Wexner scale), but not in manometry.




clinical factors that can predict
the efficacy of BF for FI
treatment and evaluate the
utility of tests in predicting
outcomes of treatment.
135 women with fecal incontinence of
varying etiology (aged: 60.6 ± 11.5 years)
A minimum of 4 BF sessions + anal sphincter
exercises at home; 10 min, twice a day
Assessment: manometry, rectal sensory
testing, EaU, PNTML, questionnaire
about symptoms
BF therapy was effective in the
treatment of FI. Clinical factors and
tests to predict treatment outcomes






Assessment of the effects of
PFMT with BF facilitation in the
early postpartum period on UI
and FI symptoms and related
problems, as well as the
strength and endurance of PFM.
84 women with UI and FI symptoms
Exp.: 41 (mean age: 28 ± 4.3 years)
Con.: 43 (mean age: 29 ± 5.3 years)
Exp.: supervised PFMT with vaginal
EMG-BF to facilitate—once a week for 12
weeks, session duration 45–60 min; home
PFMT 3 x 10 PFM contractions. Training
started in the 9th week post-partum
Con.: no intervention
Assessment: APFQ, manometry
PFMT with BF facilitation increased
the strength and endurance of both
PFM and anal sphincter, but the
frequency of UI and FI after 6 and
12 months remained unchanged.
Exp., experimental group; Con., control group; G., group; FI, fecal incontinence; BF, biofeedback; QoL, quality of life; PFM, Pelvic Floor Muscle; PFMT, pelvic floor muscle training; SCI,
Spinal cord injury; EAU, endoanal ultrasonography; CCCS, Cleveland Clinic Continence Score; RFI QoL, Rockwood Faecal Incontinence Quality of Life; FIQL, Fecal Incontinence Quality
of Life Scale; CGSS, Continence Grading Scale Score; FISI, Fecal incontinence severity index; UI, urinary incontinence; PNTML, pudendal nerve terminal motor latency; APFQ, Australian
Pelvic Floor Questionnaire; 3D-EAUS, three dimensional endoanal ultrasonography; EMG-BF, electromyographic biofeedback.
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5.3. PFM Electrostimulation for the Treatment of Fecal Incontinence
Electrical stimulation is a technique used to treat many pelvic floor dysfunctions which passively
contracts the stimulated muscles (here, PMF or anal sphincters). It improves the tension and muscle
strength, as well as raises patient awareness about PFM contractions. To activate the reflex initiating
peri-urethral sphincter, anal sphincter, or entire pelvic floor contraction, proper functioning of the
spinal arc is essential [89]. Electrostimulation of the pelvic floor can be performed with surface
perineal electrodes, as well as vaginal and rectal electrodes [90]. In endoanal electrical stimulation,
the vulva nerve and anal sphincter are chronically stimulated [56], which leads to improved strength
and endurance of the striated muscle (external anal sphincter) in FI patients [58]. Electrostimulation
of the rectum reduces the tendency of the sphincter to fatigue and improves the sensory function of
the rectum [87]. In most protocols, high-frequency stimulation at 50 Hz for 15–20 min twice daily is
recommended [53,56,63]. Electrostimulation is often used in combination with other physiotherapeutic
methods, which makes it difficult to separate the effects of these interventions [90]. Furthermore,
electrostimulation is considered a non-invasive, low-cost, and easily accessible therapeutic method
for the treatment of FI [91]. The effectiveness of electrostimulation has been demonstrated in women
with FI after deliveries complicated with damage to the anal sphincters [53,54] and in women with
chronic [55,56] or idiopathic FI [63]. The effectiveness of ES in alleviating FI symptoms has also been
compared with other physiotherapeutic techniques such as BF [54] or PFMT [56]. The impact of ES on
the quality of life has also been assessed [53–55].
It should be noted that electrostimulation is often combined with PFM training and biofeedback
to identify contractions and increase PFM strength [92]. As a method of passive muscle stimulation,
it is a valuable therapeutic tool in the case of severe muscle weakness, in which the contraction necessary
for PFM or BF training is ineffective. PFM electrostimulation has been recommended by ICI-ICS as an
FI treatment with the grade of recommendation of B. Similarly to BF, its use is recommended in the
second line of treatment [83]. Descriptions of the studies included in the review are given in Table 7.
5.4. PFM Magnetic Stimulation for the Treatment of Fecal Incontinence
Magnetic stimulation (MS) is a non-invasive method that has been suggested for use as an
alternative to electrostimulation [93]. In MS, an electric current is induced by a time-varying magnetic
field [94]. The key to the effectiveness of MS in the treatment of pelvic floor disorders is depolarization
of nerve fibers, which leads to a gradual increase in strength and endurance of the PFM [95]. Due to the
lack of an internal probe and the ability of the magnetic field to pass through clothing, MS is painless
and well-tolerated by patients with pelvic floor dysfunction [94,96]. Nevertheless, this method has
been verified in only a few studies, which makes it impossible to recognize it as an effective and
recommended technique in the treatment of FI at present. Further research is still needed; however,
the existing results are promising. In the study by Brusciano et al. [95], a frequency of 50–60 Hz was
used in the treatment of FI in both women and men. The treatment time was 15 min, performed
once a week for 8 weeks [95]. In turn, Schobeiri et al. [64] verified the efficacy of MS in FI treatment
exclusively among women. The frequency of the magnetic field was increased gradually from 5 to
50 Hz. A single therapeutic session lasted 20 min and was performed twice a week for two months.
Both studies showed a significant decrease in symptoms of FI [64,95]. Nevertheless, this technique has
not been recommended by the ICI-ICS, so far. It should also be mentioned that MS can cause minor
side effects [64]. At 100% magnetic field intensity, patients experienced tingling and numbness in the
buttocks and back of the thigh. Moreover, after the end of stimulation, most of the examined women
felt dull fatigue in the buttocks [64]. Detailed descriptions of the studies included in the review are
given in Table 8.
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Table 7. Characterization of selected studies on the effects of electrostimulation (ES) on the severity of fecal incontinence symptoms.
Reference Main Objective Participants Intervention Outcome




Comparison of the effect of BF
vs. ES in the treatment of
postdelivery FI.





2 sessions with a therapist, and then twice a day for
8 weeks at home.
BF: 30 min, 5 sets of 3 s, 10 s and as long as it can be
kept with a minimum 50 percent of amplitude of the
three-second contraction
ES: with anal probe; frequency 30–40 Hz, pulse width:
200 ms, up to 80 mAmp, time: 20 min.
Assessment: Wexner score, FIQL, RQL
No improvement was observed after
BF or ES therapy in FI symptoms
(Wexner score) and quality of life
(FIQL) in women with postdelivery
FI problem.
Both therapies improved the
subjective perception of fecal





Assessment of the effects of
DGN stimulation on FI
symptoms.
Nine women with idiopathic FI
(median age, 60 years; 34–68 years)
ES: twice a day for 3 weeks; 15 min, pulse width
200 µs; frequency 20 Hz.
Assessment: VAS, FIQL, bowel habit diary, EA USG,
Wexner score, St. Mark’s scale, manometry
After electrostimulation of DGN,
the symptoms of FI were reduced
(Wexner score, St. Mark’s scale),
and the effect was maintained also
3 weeks after the end of treatment.




Comparison of the effectiveness
of intra-anal EMG-BF with
intra-anal EMG-BF combined
with anal sphincter ES in the
treatment of postpartum FI, as
well as QoL of treated patients.
54 women with FI after obstetric injury
BF + ES: 28 (median age 35 years, range
23–39),
BF: 26 (median age 32 years, range 22–42)
In both groups: daily PFMT for 12 weeks
BF + ES: PFEs with EMG-BF or intra-anal BF and
intra-anal electrical stimulation for 20 min,
once per week.
BF: PFEs with EMG-BF or intra-anal BF once per week.
Assessment: FIQL, questionnaire to determine
continence score, manometry, EA USG
In both groups, there was significant
improvement in FI symptoms and
quality of life. ES did not bring any
additional benefits.
Healy et al. (2006),
Ireland [55]
A prospective study
Comparison of the effectiveness




38 women with FI
(mean age: 55 years; range 40–78)
G.I: 21
G.II: 17
G.I: low-frequency endo-anal ES at home with
sequence of 3, 10, 20, 30, 40, 10 Hz frequencies (4 s on/4
s off), 1 h daily for 3 months
G.II: low frequency endo-anal ES (15 min 10 Hz + 15
min 40 Hz) with biofeedback; 2 series 15 min; once a
week under the supervision of a physiotherapist for 3
months
Assessment: manometry, Wexner score, QoL
Low-frequency ES significantly
reduced the symptoms of FI and
improved quality of life. Daily use of
home ES significantly improved






Comparison of the effectiveness
and costs of ES at home with BF
training in women with FI.
36 women with chronic FI (mean age:
67.45 ± 7.2 years)
ES: 18 (mean age: 66.6 ± 6.6)
BF + PFMT: 18 (mean age: 68.3 ± 6.9)
ES: stimulation twice daily (25 min) for 6 weeks
BF + PFMT: once a week supervised PFMT with BF
(30–45 min) for 6 weeks and PFMT at home twice a
day, 3 series, 10 contractions for 10 s.
Assessment: VAS, VIS, HADS, intra-anal surface EMG
In both groups there was an increase
in muscle strength as well as a
decrease in FI symptoms. There were
no adverse side effects.
G., group; FI, fecal incontinence; FIQL, fecal incontinence quality of life; RQL, reduced quality of life (on visual analog scale of 0 to 10); QoL, quality of life; DGN, dorsal genital nerve; EA
USG, endoanal ultrasonography; ES, electrical stimulation; BF, biofeedback; VIS, Vaizey incontinence score; VAS, visual analog scale; HADS, Hospital Anxiety and Depression Scale; PFMT,
pelvic floor muscle training; EMG-BF, electromyographic biofeedback; PFEs, pelvic floor electrostimulation.
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Table 8. Characterization of the effects of magnetic stimulation (MS) on the severity of fecal incontinence symptoms in women.
Reference Main Objective Participants Intervention Outcome




Assessment of the usefulness of
EXMI in alleviating FI
symptoms in women with
underactive pelvic floor.
16 women with FI and underactive PFM
(mean age 57 years)
EXMI in a sitting position on a chair inducing an
alternating magnetic field, frequency from 5 to 50 Hz,
pulse 8 s, rest 4 s, for 20 min, twice a week for 8 weeks.
Follow-up after 12 weeks
Assessment: CCFIS, MR, endovaginal ultrasound,
PFM examination with a Kegel Perineometer
EXMI alleviates the FI symptoms
among women with an underactive
pelvic floor (CCFIS). Pelvic floor rest
and squeeze pressures have
improved significantly.
EXMI, extracorporeal magnetic stimulation; FI, fecal incontinence; CCFIS, Cleveland Clinic Fecal Incontinence Score; MR, magnetic resonance; PFM, pelvic floor muscles.
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5.5. Reccomendations for Conservative FI Treatment
According to the recommendations of the International Continence Society (ICS) from 2019 for the
treatment of women with fecal incontinence, education (grade of recommendation (GoR) B/C), dietary
change (GoR B), supplements (GoR A), change of toilet habits (GoR C), and the use of absorptive products
(GoR B) are recommended as a primary intervention [82], while PFMT (GoR B) and Biofeedback (GoR A)
are recommended as secondary interventions in the treatment of FI [82]. Nevertheless, according to
the recommendations of the 6th edition of International Consultation on Incontinence (ICI), PFMT
should be implemented as an early intervention in FI treatment (GoR B) [83], while BF should be the
second line after behavioral methods and conservative treatment (GoR A). Moreover, studies have
confirmed that BF is more effective in combination with PFMT (level of evidence 1). Stand-alone PFMT
appears to be effective, but the results so far are contradictory (level of evidence 2). Home BF or ES is
an effective form of therapy, but younger patients benefit more than older patients (level of evidence 2,
grade of recommendation B). In the 6th edition of the ICI, the opinion on ES was also changed. Studies
have suggested that low ES frequencies are not effective, even when combined with BF, but ES therapy
at 30 Hz with BF performed twice a day for at least six months is effective (level of evidence 2, grade
of recommendation B). At present, MS therapy is not recommended by the ICI for the treatment of
FI [82,83]. The quality of evidence of physiotherapy techniques in FI is presented in Table 9 (according
the ICI-ICS standards).
Table 9. Quality of evidence of physiotherapy techniques in FI in the ICI-ICS standards.
Method Level of Evidence Grade of Recommendation Line of Treatment (ICI)
PFMT 2 B [82] Primary
BF 1 A [82] Secondary
ES 2 B [83] Secondary
MS - - -
PFMT, Pelvic Floor Muscle Training; BF, Biofeedback; ES, Electrostimulation; MS, Magnetostimulation.
6. Limitation of the Study
The presented review has some limitations, including the small number of papers describing
the effects of physiotherapy in the treatment of FI in women. We had to reject many papers, due to
the fact that they were related to both women and men and as it was not possible to separate the
results by gender. Moreover, the presented studies recruited a relatively small number of patients who
showed a large variety of FI symptoms (from mild to severe), which were often not included in the
analysis of the effectiveness of a given method. The small number of papers, as well as the low quality
of many of them, made it impossible to carry out a statistical evaluation of the effectiveness of the
methods and meta-analysis. However, it should be noted that the review was not limited to only RCTs.
In addition, works from the years 2000–2020 were analyzed, which is a wide range of time covering
the current literature.
7. Conclusions
The possibility of fecal incontinence in women is generally underestimated by doctors, even though
it affects about 0.25–6% [3] of the population. Some of the most common causes of these problems are
changes resulting from iatrogenic trauma in young women, systemic diseases, and inadequate hygiene
habits, which lead to symptoms at a later age. Some of the causes of these complaints can be eliminated
by effective prophylaxis, both in the form of education introducing appropriate toilet habits (to reduce
intra-abdominal pressure) and dietary habits (to maintain proper consistency of stool), early diagnosis
of systemic diseases occurring with polyneuropathy, and active prevention through physiotherapy
techniques. In each of these cases, there should be close co-operation between the patient and the
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therapist. It seems that a good solution is to create teams consisting of a doctor, a physiotherapist,
a dietician, and a psychologist. Therefore, FI management should be multidisciplinary. In the case of
ailments, correct diagnosis based on correct subjective and physical examination (including palpation)
is essential. It is also extremely important to assess the defects in the patient’s posture. Treatment,
especially in cases with a lower degree of severity of the disease, should start from conservative
management including physiotherapy and pharmacotherapy.
On the basis of the presented results, it can be concluded that physiotherapy is an effective method
of conservative FI treatment in women. Physiotherapeutic techniques in FI management include pelvic
floor muscle training (mainly anal sphincter), BF, ES, MS, and perineal massage. Physiotherapy plays
an important role in the treatment of pre- and post-operative FI. PFM training can also be performed by
pregnant women, in order to reduce the risk of FI development in the antenatal and postnatal periods.
Moreover, Lacima et al. showed a tendency for younger patients to obtain better clinical results after
treatment than older patients [61].
Regular and appropriately adjusted rehabilitation leads to increases in strength, endurance,
tension, and co-ordination and sensory activity of anal sphincter muscles and levator ani. In order
to achieve the best possible results in FI physiotherapy, the combination of different techniques is
recommended. In patients who have problems performing conscious, isolated contraction of the
anal sphincter muscles, PFM training in combination with BF should be conducted. In the latest
recommendations issued by the ICS (2019), the highest level of recommendation (A) was achieved by
BF. In turn, PFMT and ES were classified at level B. Additionally, magnetic stimulation and perineal
massage can be used in the treatment of FI. Physiotherapeutic techniques demonstrated high efficiency
in reducing the symptoms of FI in many studies. However, due to the small number of high-quality
publications on the use of physiotherapy in the treatment of FI, RCT studies are still needed.
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